Evidence map›Paper›PMID 30813592›Full record

ArticleJournal of clinical medicine2019

Maria Ángeles Jiménez-Sousa, Alejandra Fadrique, Pilar Liu, Amanda Fernández-Rodríguez, Mario Lorenzo-López, Esther Gómez-Sánchez, Alicia Gómez-Sanz, María Heredia-Rodríguez, Estefanía Gómez-Pesquera, Isidoro Martínez and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. [Association of gene polymorphisms ofZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Maria Ángeles Jiménez-SousaUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Spain. jimenezsousa@isciii.es.
Alejandra FadriqueDepartamento de Anestesiología y Reanimación, Hospital Clínico Universitario, 47005 Valladolid, Spain. alejandrafadrique@gmail.com.
Pilar LiuDepartamento de Anestesiología y Reanimación, Hospital Clínico Universitario, 47005 Valladolid, Spain. liupili@gmail.com.
Amanda Fernández-RodríguezUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Spain. amandafr@isciii.es.ORCID 0000-0002-5110-2213
Mario Lorenzo-LópezDepartamento de Anestesiología y Reanimación, Hospital Clínico Universitario, 47005 Valladolid, Spain. mariolorenzo17@yahoo.es.
Esther Gómez-SánchezDepartamento de Anestesiología y Reanimación, Hospital Clínico Universitario, 47005 Valladolid, Spain. esthergzam@hotmail.com.
Alicia Gómez-SanzUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Spain. algomez@isciii.es.
María Heredia-RodríguezDepartamento de Anestesiología y Reanimación, Hospital Clínico Universitario, 47005 Valladolid, Spain. maria_her_05@hotmail.com.
Estefanía Gómez-PesqueraDepartamento de Anestesiología y Reanimación, Hospital Clínico Universitario, 47005 Valladolid, Spain. egp29@hotmail.com.
Isidoro MartínezUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Spain. imago@isciii.es.ORCID 0000-0002-9949-9264
Eduardo TamayoDepartamento de Anestesiología y Reanimación, Hospital Clínico Universitario, 47005 Valladolid, Spain. tamayo@med.uva.es.
Salvador ResinoUnidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Spain. sresino@isciii.es.ORCID 0000-0001-8783-0450
Hospital Clínico Universitario de Valladolid · ESInstituto de Salud Carlos III · ES

Funding

Consejería de Sanidad, Junta de Castilla y León GRS 463/A/10Consejería de Sanidad, Junta de Castilla y León GRS 773/A/13Instituto de Salud Carlos III CP14CIII/00010Instituto de Salud Carlos III PI15/01451Pfizer UK CT25-ESP01-01
6 · The paper itself

Abstract

backgroundIn many immune-related diseases, inflammatory responses and several clinical outcomes are related to increased NF-κB activity. We aimed to evaluate whether SNPs related to the NF-κB signaling pathway are associated with higher susceptibility to infection, septic shock, and septic-shock-related death in European patients who underwent major surgery.

methodsWe performed a case-control study on 184 patients with septic shock and 212 with systemic inflammatory response syndrome, and a longitudinal substudy on septic shock patients. Thirty-three SNPs within genes belonging to or regulating the NF-κB signaling pathway were genotyped by Agena Bioscience's MassARRAY platform.

resultsNo significant results were found for susceptibility to infection and septic shock in the multivariate analysis after adjusting for multiple comparisons. Regarding septic-shock-related death, patients with

conclusionsThe SNPs in the genes

Indexed as

major surgeryMyD88septic shockSNPssurvivalTNFAIP3TNIP1

Identifiers

PMID30813592
PMCPMC6463255
OpenAlexW2917634462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.